Integrating genetic markers, such as those weve identified in the GLP1R and GIPR genes, with clinical factors provides a clearer picture of how a patients unique biology may interact with a specific therapy, allowing both patients and their doctors to proactively manage expectations and tailor care with greater precision from day one. A Sincere Thank You to Our Participants The GLP-1 Study is ongoing, and our survey is designed to allow participants to share their journey over time so we can continue to investigate how these medications are associated with genetics and health
It also offers flexibility for patients already on the weekly injection: those on 2.4 mg semaglutide once weekly can be transitioned directly to the 25 mg tablet (MHRA, 2026)
switching formulations alone typically does not reduce symptoms
Phoenix NP is a cash-pay telehealth clinic, meaning insurance is not required or accepted for provider services
Here are common microdose calculations at a 5 mg/mL concentration: 0.5 mg dose: (0.5 / 5.0) x 100 = 10 units 0.75 mg dose: (0.75 / 5.0) x 100 = 15 units 1.0 mg dose: (1.0 / 5.0) x 100 = 20 units 1.25 mg dose: (1.25 / 5.0) x 100 = 25 units 1.5 mg dose: (1.5 / 5.0) x 100 = 30 units 2.0 mg dose: (2.0 / 5.0) x 100 = 40 units 2.5 mg dose: (2.5 / 5.0) x 100 = 50 units At a 10 mg/mL concentration, those same doses require half the volume